Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Feb 21;282(6264):590–594. doi: 10.1136/bmj.282.6264.590

Prostaglandins in vascular disease: a seminal approach.

J R Mitchell
PMCID: PMC1504467  PMID: 6781584

Full text

PDF
590

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis T. M., Mitchell M. D., Turner R. C. Prostacyclin and thromboxane metabolites in diabetes. Lancet. 1979 Oct 13;2(8146):789–790. doi: 10.1016/s0140-6736(79)92131-7. [DOI] [PubMed] [Google Scholar]
  2. Dollery C. T., Friedman L. A., Hensby C. N., Kohner E., Lewis P. J., Porta M., Webster J. Circulating prostacyclin may be reduced in diabetes. Lancet. 1979 Dec 22;2(8156-8157):1365–1365. doi: 10.1016/s0140-6736(79)92844-7. [DOI] [PubMed] [Google Scholar]
  3. Dyerberg J., Bang H. O., Stoffersen E., Moncada S., Vane J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978 Jul 15;2(8081):117–119. doi: 10.1016/s0140-6736(78)91505-2. [DOI] [PubMed] [Google Scholar]
  4. Emmons P. R., Hampton J. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J. 1967 May 20;2(5550):468–472. doi: 10.1136/bmj.2.5550.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature. 1965 Oct 16;208(5007):255–257. doi: 10.1038/208255a0. [DOI] [PubMed] [Google Scholar]
  6. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of dipyridamole on human platelet behaviour. Lancet. 1965 Sep 25;2(7413):603–606. doi: 10.1016/s0140-6736(65)90515-5. [DOI] [PubMed] [Google Scholar]
  7. GAARDER A., JONSEN J., LALAND S., HELLEM A., OWREN P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961 Nov 11;192:531–532. doi: 10.1038/192531a0. [DOI] [PubMed] [Google Scholar]
  8. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hampton J. R., Mitchell J. R. Platelet electrophoresis: the present position. Thromb Diath Haemorrh. 1974 May 15;31(2):204–244. [PubMed] [Google Scholar]
  10. Hirai A., Hamazaki T., Terano T., Nishikawa T., Tamura Y., Kamugai A., Jajiki J. Eicosapentaenoic acid and platelet function in Japanese. Lancet. 1980 Nov 22;2(8204):1132–1133. doi: 10.1016/s0140-6736(80)92558-1. [DOI] [PubMed] [Google Scholar]
  11. Johnson M., Harrison H. E., Raftery A. T., Elder J. B. Vascular prostacyclin may be reduced in diabetes in man. Lancet. 1979 Feb 10;1(8111):325–326. doi: 10.1016/s0140-6736(79)90737-2. [DOI] [PubMed] [Google Scholar]
  12. Kernoff P. B., Willis A. L., Stone K. J., Davies J. A., McNicol G. P. Antithrombotic potential of dihomo-gamma-linolenic acid in man. Br Med J. 1977 Dec 3;2(6100):1441–1444. doi: 10.1136/bmj.2.6100.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Longmore D. B., Bennett G., Gueirrara D., Smith M., Bunting S., Moncada S., Reed P., Read N. G., Vane J. R. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds. Lancet. 1979 May 12;1(8124):1002–1005. doi: 10.1016/s0140-6736(79)92756-9. [DOI] [PubMed] [Google Scholar]
  14. MITCHELL J. R., SHARP A. A. PLATELET CLUMPING IN VITRO. Br J Haematol. 1964 Jan;10:78–93. doi: 10.1111/j.1365-2141.1964.tb00681.x. [DOI] [PubMed] [Google Scholar]
  15. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  16. Mitchell J. R. Clinical events resulting from thrombus formation. Br Med Bull. 1978 May;34(2):103–106. doi: 10.1093/oxfordjournals.bmb.a071478. [DOI] [PubMed] [Google Scholar]
  17. Mitchell J. R. Secondary prevention of myocardial infarction--the present state of the ART. Br Med J. 1980 May 3;280(6223):1128–1130. doi: 10.1136/bmj.280.6223.1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  19. Moncada S., Herman A. G., Higgs E. A., Vane J. R. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res. 1977 Sep;11(3):323–344. doi: 10.1016/0049-3848(77)90185-2. [DOI] [PubMed] [Google Scholar]
  20. Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979 May 17;300(20):1142–1147. doi: 10.1056/NEJM197905173002006. [DOI] [PubMed] [Google Scholar]
  21. Needleman P., Moncada S., Bunting S., Vane J. R., Hamberg M., Samuelsson B. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature. 1976 Jun 17;261(5561):558–560. doi: 10.1038/261558a0. [DOI] [PubMed] [Google Scholar]
  22. Roth G. J., Stanford N., Majerus P. W. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3073–3076. doi: 10.1073/pnas.72.8.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. SMYTHE H. A., OGRYZLO M. A., MURPHY E. A., MUSTARD J. F. THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN. Can Med Assoc J. 1965 Apr 10;92:818–821. [PMC free article] [PubMed] [Google Scholar]
  24. Siess W., Roth P., Scherer B., Kurzmann I., Böhlig B., Weber P. C. Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet. 1980 Mar 1;1(8166):441–444. doi: 10.1016/s0140-6736(80)90995-2. [DOI] [PubMed] [Google Scholar]
  25. Silberbauer K., Schernthaner G., Sinzinger H., Piza-Katzer H., Winter M. Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med. 1979 Feb 15;300(7):366–367. [PubMed] [Google Scholar]
  26. Smith J. B. The prostanoids in hemostasis and thrombosis: a review. Am J Pathol. 1980 Jun;99(3):743–804. [PMC free article] [PubMed] [Google Scholar]
  27. Steer M. L., MacIntyre D. E., Levine L., Salzman E. W. Is prostacyclin a physiologically important circulating anti-platelet agent? Nature. 1980 Jan 10;283(5743):194–195. doi: 10.1038/283194a0. [DOI] [PubMed] [Google Scholar]
  28. Stuart M. J., Elrad H., Graeber J. E., Hakanson D. O., Sunderji S. G., Barvinchak M. K. Increased synthesis of prostaglandin endoperoxides and platelet hyperfunction in infants of mothers with diabetes mellitus. J Lab Clin Med. 1979 Jul;94(1):12–26. [PubMed] [Google Scholar]
  29. Stuart M. J., Gerrard J. M., White J. G. Effect of cholesterol on production of thromboxane b2 by platelets in vitro. N Engl J Med. 1980 Jan 3;302(1):6–10. doi: 10.1056/NEJM198001033020102. [DOI] [PubMed] [Google Scholar]
  30. Szczeklik A., Nizankowski R., Skawinski S., Szczeklik J., Gluszko P., Gryglewski R. J. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet. 1979 May 26;1(8126):1111–1114. doi: 10.1016/s0140-6736(79)91792-6. [DOI] [PubMed] [Google Scholar]
  31. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  32. Weiss H. J., Aledort L. M. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967 Sep 2;2(7514):495–497. doi: 10.1016/s0140-6736(67)91658-3. [DOI] [PubMed] [Google Scholar]
  33. Woods H. F., Ash G., Weston M. J., Bunting S., Moncada S., Vane J. R. Prostacyclin can replace heparin in haemodialysis in dogs. Lancet. 1978 Nov 18;2(8099):1075–1077. doi: 10.1016/s0140-6736(78)91806-8. [DOI] [PubMed] [Google Scholar]
  34. Zahavi J., Price A. J., Westwick J., Scully M. F., Al-Hasani S. F., Honey A. C., Dubiel M., Kakkar V. V. Enhanced in-vivo platelet release reaction, increased thromboxane synthesis, and decreased prostacyclin release after tourniquet ischaemia. Lancet. 1980 Sep 27;2(8196):663–667. doi: 10.1016/s0140-6736(80)92706-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES